Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder.

Source:http://linkedlifedata.com/resource/pubmed/id/2018816

Biol. Psychiatry 1991 Mar 1 29 5 418-26

Download in:

View as

General Info

PMID
2018816